Navigation Links
A novel 'man and machine' decision support system makes malaria diagnostics more effective
Date:8/21/2014

A Finnish-Swedish research group at the Institute for Molecular Medicine Finland (FIMM), University of Helsinki, and Karolinska institutet, Stockholm, has developed a novel "man and machine" decision support system for diagnosing malaria infection. This innovative diagnostic aid was described in PLOS One scientific journal today, 21 August. The method is based on computer vision algorithms similar to those used in facial recognition systems combined with visualization of only the diagnostically most relevant areas. Tablet computers can be utilized in viewing the images.

In this newly developed method, a thin layer of blood smeared on a microscope slide is first digitized. The algorithm analyzes more than 50,000 red blood cells per sample and ranks them according to the probability of infection. Then the program creates a panel containing images of more than a hundred most likely infected cells and presents that panel to the user. The final diagnosis is done by a health-care professional based on the visualized images.

By utilizing a set of existing, already diagnosed samples, the researchers were able to show that the accuracy of this method was comparable to the quality criteria defined by the World Health Organization. In the test setting, more than 90% of the infected samples were accurately diagnosed based on the panel. The few problematic samples were of low quality and in a true diagnostic setting would have led to further analyses.

"We are not suggesting that the whole malaria diagnostic process could or should be automated. Rather, our aim is to develop methods that are significantly less labor intensive than the traditional ones and have a potential to considerably increase the throughput in malaria diagnostics", said Research Director Johan Lundin (MD, PhD) from the Institute for Molecular Medicine Finland, FIMM.

"The equipment needed for digitization of the samples is a challenge in developed countries. In the next phase of our project we will test the system in combination with inexpensive mobile microscopy devices that our group has also developed", told the shared first author of the article Nina Linder (MD, PhD) from FIMM.

The developed support system can be applied in various other fields of medicine. In addition to other infectious diseases such as tuberculosis, the research group is planning to test the system fro cancer diagnostics in tissue samples.

"There is also a strong need for fast and accurate methods for measuring the malaria parasite load in a sample. Various malaria drug screening programs are underway and the parasite load in a large number of samples needs to be quantified for determining the efficacy of potential drugs. We are further developing the computer algorithms used in this study to meet this need as well", Dr. Linder continued.

There are more than 200 million new malaria cases yearly. High-quality microscopy is still the most accurate method for detection of malaria infection. However, microscopy requires well-trained personnel and can be very time-consuming when performed according to the recommendations. In 2012, less than half of the suspected malaria cases in Sub-Saharan Africa received a diagnostic test. The workload of the health-care personnel is excessive thus contributing to the demonstrably low accuracy of microscopy.

"The new method of imaging and analysis can revolutionise the point of care diagnostics of not only malaria but also several diseases where diagnosis depends on microscopy. The action may lead to 'market rupture' in the field of disease diagnostics", says Professor Vinod Diwan from Karolinska Institutet.


'/>"/>

Contact: Dr. Nina Linder
nina.linder@helsinki.fi
358-445-555-407
University of Helsinki
Source:Eurekalert  

Related biology technology :

1. Novel chip-based platform could simplify measurements of single molecules
2. Synthetic Biologics Academic Collaborator to Present Novel Monoclonal Antibody Combination for Treatment of Whooping Cough (Pertussis) at 54th ICAAC
3. Diagenode Launches Novel CRISPR/Cas9 Monoclonal Antibody
4. Harnessing Novel Techniques to Beat Dreadful Diabetes
5. University of Illinois researchers demonstrate novel, tunable nanoantennas
6. Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks
7. Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information
8. Sequenom Announces Issuance Of European Patent For Novel Methods Of Detecting Fetal Aneuploidy
9. Data Highlights BGB324 as a Potential Novel Treatment Option for Drug Resistant Chronic Myeloid Leukemia
10. NKT Therapeutics Identifies Novel anti-iNKT Antibodies for Depleting or Activating iNKT Cells
11. Phase 2a Findings Demonstrate that CSL112, A Novel Apolipoprotein A-I Infusion Therapy, Has a Favorable Safety Profile, is Well Tolerated and Increases Cholesterol Efflux Capacity in Stable Atherothrombotic Patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A novel 'man and machine' decision support system makes malaria diagnostics more effective
(Date:3/23/2017)... 23, 2017  BioPharmX Corporation (NYSE MKT: BPMX), ... dermatology market, today reported financial results for the ... will provide an update on the company,s clinical ... "We are pleased to report that last ... said President Anja Krammer. "We achieved key clinical ...
(Date:3/23/2017)...  Agriculture technology company Cool Planet has closed on ... to commercialize its Cool Terra and Cool Fauna Engineered ... that are simultaneously profitable as well as sustainable and ... months. This latest round of funding was led by ... The company,s primary product, Cool Terra, can improve ...
(Date:3/22/2017)...  Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical ... address significant unmet medical needs in rare diseases, ... ended December 31, 2016. "2016 ... we broadened our pipeline and pursued our vision ... with an initial focus on endocrinology," said ...
(Date:3/22/2017)... , March 22, 2017 The ... states a research report by Transparency Market Research (TMR). ... Amgen Inc., and AbbVie Inc., accounted for a share ... prominent players in this market are focusing aggressively on ... portfolio, which is likely to lead to market consolidation ...
Breaking Biology Technology:
(Date:2/26/2017)... , Feb. 25, 2017  Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... Recidivism and Reentry. "Too often, too ... prisons and county jails are trying to tackle ... inmates and friends and family members. While significant steps ...
(Date:2/21/2017)... , February 21, 2017 ... 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr als ... einige Hindernisse zu überwinden gilt, um diese Prognose zu ... ... anderem die Mobilisierung der finanziellen Mittel für die Biobank, ...
(Date:2/13/2017)... 13, 2017 Former 9/11 Commission border counsel ... Janice Kephart of Identity Strategy Partners, LLP, ... Trump,s "Executive Order: Protecting the Nation From Foreign ... "As President Trump,s ,Travel Ban, Executive Order ... essentially banned the travel ban, it is important that ...
Breaking Biology News(10 mins):